ViviCells International Key Fundamental Indicators

VCII Stock  USD 0.0001  0.00  0.00%   
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of ViviCells International, as well as the relationship between them.

ViviCells International Total Revenue

3.34 Million

ViviCells International's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing ViviCells International's valuation are provided below:
Gross Profit
1.1 M
Profit Margin
(0.09)
Market Capitalization
23.4 K
Revenue
5.1 M
Quarterly Revenue Growth
(0.27)
We have found eighty-four available fundamental trend indicators for ViviCells International, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of ViviCells International current fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 4.6 M. Enterprise Value is estimated to decrease to about 4.7 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
As of now, ViviCells International's Income Before Tax is increasing as compared to previous years. The ViviCells International's current Income Tax Expense is estimated to increase to about 278.9 K, while Selling General Administrative is projected to decrease to under 820 K.
  
Build AI portfolio with ViviCells Stock

ViviCells International Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets4.9 M6.1 M5.2 M
Slightly volatile
Other Current Liabilities239.2 K382.9 K316.8 K
Slightly volatile
Total Current Liabilities684.1 K780.4 K678.2 K
Slightly volatile
Total Stockholder Equity1.3 M2.2 M1.8 M
Slightly volatile
Net Tangible Assets1.2 M2.2 M1.8 M
Slightly volatile
Accounts Payable272.7 K267.4 K299.1 K
Slightly volatile
Cash22.9 K34 K28.4 K
Slightly volatile
Other Assets14.7 K23.2 K19.2 K
Slightly volatile
Long Term Debt2.2 M2.4 M2.6 M
Slightly volatile
Net Receivables3.2 MM3.5 M
Slightly volatile
Inventory1.5 M1.9 M1.6 M
Slightly volatile
Total Liabilities3.7 M3.9 M3.4 M
Slightly volatile
Short and Long Term Debt23.9 K25.7 K22.5 K
Slightly volatile
Total Current Assets4.8 MM5.1 M
Slightly volatile
Intangible Assets25.3 K26.6 K33.9 K
Slightly volatile
Common Stock75.4 K108.9 K91.3 K
Slightly volatile
Property Plant Equipment88 K110.7 K94.7 K
Slightly volatile

ViviCells International Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative820 KM882.1 K
Slightly volatile
Total Revenue3.3 M4.3 M3.7 M
Slightly volatile
Gross Profit1.3 MM1.6 M
Slightly volatile
Other Operating Expenses4.6 K3.8 K4.7 K
Slightly volatile
Cost Of Revenue2.1 M2.4 MM
Slightly volatile
Total Operating Expenses2.9 M3.4 M2.9 M
Slightly volatile

ViviCells International Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock787828727
Slightly volatile
Net Borrowings1.3 M1.4 M1.2 M
Slightly volatile
Depreciation42.2 K31.3 K36 K
Slightly volatile
Capital Expenditures37.5 K56.4 K47.4 K
Slightly volatile
Total Cash From Financing Activities1.5 M1.5 M1.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio17.1 K19.2 K21 K
Slightly volatile
PTB Ratio6.496.842.7 K
Slightly volatile
Days Sales Outstanding242272297
Slightly volatile
Book Value Per Share0.00680.00720.0104
Slightly volatile
PB Ratio6.496.842.7 K
Slightly volatile
EV To Sales17.1 K19.2 K21 K
Slightly volatile
Inventory Turnover1.341.51.6399
Slightly volatile
Days Of Inventory On Hand175197215
Slightly volatile
Payables Turnover7.348.269.0167
Slightly volatile
Capex To Revenue0.00930.01040.0114
Slightly volatile
Cash Per Share0.00.02.0E-4
Slightly volatile
Days Payables Outstanding31.8235.7939.0639
Slightly volatile
Income Quality67.075.3782.2675
Slightly volatile
Intangibles To Total Assets0.00440.0050.0055
Slightly volatile
Current Ratio0.04230.04460.5062
Slightly volatile
Tangible Book Value Per Share0.00680.00720.0104
Slightly volatile
Receivables Turnover0.971.091.1849
Slightly volatile
Shareholders Equity Per Share0.00680.00720.0104
Slightly volatile
Debt To Equity0.110.120.1742
Slightly volatile
Capex Per Share0.00150.00170.0018
Slightly volatile
Revenue Per Share0.130.150.1596
Slightly volatile
Interest Debt Per Share7.0E-47.0E-40.0078
Slightly volatile
Debt To Assets0.190.10.116
Pretty Stable
Operating Cycle417469512
Slightly volatile
Price Book Value Ratio6.496.842.7 K
Slightly volatile
Price Earnings To Growth Ratio4.327.314.3235
Slightly volatile
Days Of Payables Outstanding31.8235.7939.0639
Slightly volatile
Pretax Profit Margin0.04090.0460.0502
Slightly volatile
Effective Tax Rate0.860.961.0482
Slightly volatile
Company Equity Multiplier1.611.321.2784
Pretty Stable
Long Term Debt To Capitalization0.450.510.5526
Slightly volatile
Total Debt To Capitalization0.210.110.1253
Pretty Stable
Debt Equity Ratio0.110.120.1742
Slightly volatile
Quick Ratio0.04230.04460.3957
Slightly volatile
Cash Ratio0.03310.03490.1569
Slightly volatile
Cash Conversion Cycle385433473
Slightly volatile
Days Of Inventory Outstanding175197215
Slightly volatile
Days Of Sales Outstanding242272297
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.830.941.0222
Slightly volatile
Price To Book Ratio6.496.842.7 K
Slightly volatile
Fixed Asset Turnover35.2239.6243.2424
Slightly volatile
Debt Ratio0.190.10.116
Pretty Stable
Price Sales Ratio17.1 K19.2 K21 K
Slightly volatile
Asset Turnover0.640.720.7823
Slightly volatile
Gross Profit Margin0.290.320.3505
Slightly volatile
Price Fair Value6.496.842.7 K
Slightly volatile

ViviCells International Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.6 M4.8 M5.3 B
Slightly volatile
Enterprise Value4.7 M4.9 M5.3 B
Slightly volatile

ViviCells Profit Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for ViviCells International is extremely important. It helps to project a fair market value of ViviCells Stock properly, considering its historical fundamentals such as Profit Margin. Since ViviCells International's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ViviCells International's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ViviCells International's interrelated accounts and indicators.
Is there potential for Independent Power and Renewable Electricity Producers market expansion? Will ViviCells introduce new products? Factors like these will boost the valuation of ViviCells International. If investors know ViviCells will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about ViviCells International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth
(0.27)
ViviCells International's market price often diverges from its book value, the accounting figure shown on ViviCells's balance sheet. Smart investors calculate ViviCells International's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since ViviCells International's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ViviCells International's value and its price as these two are different measures arrived at by different means. Investors typically determine if ViviCells International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ViviCells International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ViviCells International 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ViviCells International's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ViviCells International.
0.00
11/07/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/05/2026
0.00
If you would invest  0.00  in ViviCells International on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding ViviCells International or generate 0.0% return on investment in ViviCells International over 90 days. ViviCells International, Inc. operates as a stem cell preservation company More

ViviCells International Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ViviCells International's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ViviCells International upside and downside potential and time the market with a certain degree of confidence.

ViviCells International Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for ViviCells International's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ViviCells International's standard deviation. In reality, there are many statistical measures that can use ViviCells International historical prices to predict the future ViviCells International's volatility.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000840.00
Details
Naive
Forecast
LowNextHigh
0.00010.00010.0001
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00010.00010.0001
Details

ViviCells International Backtested Returns

We have found three technical indicators for ViviCells International, which you can use to evaluate the volatility of the company. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and ViviCells International are completely uncorrelated.

Auto-correlation

    
  1.00  

Perfect predictability

ViviCells International has perfect predictability. Overlapping area represents the amount of predictability between ViviCells International time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ViviCells International price movement. The serial correlation of 1.0 indicates that 100.0% of current ViviCells International price fluctuation can be explain by its past prices.
Correlation Coefficient1.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, ViviCells International has a Profit Margin of -0.0857%. This is 100.96% lower than that of the Independent Power and Renewable Electricity Producers sector and significantly lower than that of the Utilities industry. The profit margin for all United States stocks is 93.25% lower than that of the firm.

ViviCells International Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ViviCells International's current stock value. Our valuation model uses many indicators to compare ViviCells International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ViviCells International competition to find correlations between indicators driving ViviCells International's intrinsic value. More Info.
ViviCells International is rated first in profit margin category among its peers. It is rated first in operating margin category among its peers . As of now, ViviCells International's Net Loss is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ViviCells International's earnings, one of the primary drivers of an investment's value.

ViviCells Profit Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ViviCells International's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ViviCells International could also be used in its relative valuation, which is a method of valuing ViviCells International by comparing valuation metrics of similar companies.
ViviCells International is currently under evaluation in profit margin category among its peers.

ViviCells Fundamentals

About ViviCells International Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ViviCells International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ViviCells International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ViviCells International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue4.3 M3.3 M
Cost Of Revenue2.4 M2.1 M
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.15  0.13 
Ebit Per Revenue(0.02)(0.02)

Currently Active Assets on Macroaxis

When determining whether ViviCells International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ViviCells International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivicells International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivicells International Stock:
Check out
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is there potential for Independent Power and Renewable Electricity Producers market expansion? Will ViviCells introduce new products? Factors like these will boost the valuation of ViviCells International. If investors know ViviCells will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about ViviCells International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Revenue Growth
(0.27)
ViviCells International's market price often diverges from its book value, the accounting figure shown on ViviCells's balance sheet. Smart investors calculate ViviCells International's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since ViviCells International's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ViviCells International's value and its price as these two are different measures arrived at by different means. Investors typically determine if ViviCells International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ViviCells International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.